Arabia BioSystems introduces clinically proven biologic therapies designed to treat diabetic foot ulcers, gangrene, and chronic wounds across the Kingdom of Saudi Arabia.
Biologic therapies that accelerate natural tissue regeneration
Full compliance with Saudi and international regulatory standards
Alliances with world-leading biotech manufacturers
Distribution across hospitals and wound-care centers in KSA
Our portfolio of regenerative medical products targets the most challenging wound conditions where conventional treatments fall short.
Our biologic therapies stimulate the body's natural healing mechanisms to rebuild damaged tissue faster and more effectively.
Advanced wound management solutions that create optimal healing environments and minimize complications.
By addressing root causes of non-healing wounds early, we help preserve limbs and improve long-term outcomes.
Shorter hospital stays and faster recovery translate directly to better patient quality of life and reduced costs.
Saudi Arabia has one of the highest diabetes prevalence rates globally. Diabetic foot ulcers are a leading cause of lower limb amputations — a crisis that advanced regenerative medicine can directly address.